Current Report · Items 1.01, 9.01 · 8-K
SRX Global Inc
SRXHNYSE_AMERICANEQUITYCurrent
Entry into a Material Definitive Agreement
Item 1.01. Entry into a Material Definitive Agreement. As previously disclosed, on March 16, 2026, SRX Global Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain accredited investors named therein.…
Company context
Current securities
Historical securities (1)
Recent company filings
Disclosure sections
Item 1.01Item 1.01 - Entry into Material Agreement
Item
1.01. Entry into a Material Definitive Agreement.
As
previously disclosed, on March 16, 2026, SRX Global Inc., a Delaware corporation (the “Company”), entered into a Securities
Purchase Agreement (the “Securities Purchase Agreement”) with certain accredited investors named therein. Pursuant to the
Securities Purchase Agreement, up to 10,000 shares of the Company’s Series B convertible preferred stock, par value $0.001 per
share (the “Series B Preferred Stock”) and accompanying warrants (“Warrants”) to purchase shares of the Company’s
common stock, par value $0.001 per share (the “Common Stock”) may be purchased for an aggregate purchase price of up to $8.0
million in one or more closings (each a “Closing”).
On
July 17, 2026, the Company and the Required Holders, as defined in the Securities Purchase Agreement, entered into a Limited Waiver and
Consent Agreement (the “Waiver”), pursuant to which the Required Holders consented to, and waived certain rights in connection
with, the Company’s (i) declaring and paying, on August 3, 2026, a one-time cash dividend of $0.05 per share on Common Stock outstanding
to stockholders of record at the close of business on July 22, 2026; and (ii) entering into a stock repurchase plan under which the Company
may repurchase up to the lesser of (x) 10,000,000 shares of Common Stock, or (y) 50% of the issued and outstanding Common Stock at any
given time, for an aggregate purchase price not to exceed $20,000,000, during the period ending July 7, 2027.
The
foregoing description of the terms and conditions of the Waiver does not purport to be complete and is qualified in its entirety by the
full text of the form of Waiver, which is filed as an exhibit thereto.